Trials (Eugène Marquis Cancer Centre): Revision history

14 December 2025

• curprev 19:0919:09, 14 December 2025‎ Francine talk contribs‎ 109,079 bytes +185‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 108,894 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 11:5411:54, 3 December 2025‎ Francine talk contribs‎ 107,193 bytes +48‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 107,145 bytes +14,383‎ Update categories. undo

5 January 2024

• curprev 13:2113:21, 5 January 2024‎ Francine talk contribs‎ 92,762 bytes +1,633‎ No edit summary undo

3 December 2023

• curprev 23:1523:15, 3 December 2023‎ Francine talk contribs‎ 91,129 bytes +91,129‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Eugène Marquis Cancer Centre page '''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sp..."